PMID: 7938753Jan 1, 1994Paper

Oxygen free radicals are not the main factor in experimental gentamicin nephrotoxicity

Renal Failure
P StrattaR Canuto

Abstract

As a role for oxygen free radicals has been suggested in gentamicin (G) nephrotoxicity, we tested the hypothesis that exogenously administered glutathione (GSH), able to restore intracellular antioxidant potential, could be useful in reducing damage. Adult Sprague-Dawley rats were injected with saline (n = 30), subcutaneous (s.c.) G 100 (n = 23) and 150 mg/kg/day (n = 14), or s.c. G at the same dosages plus intraperitoneal (i.p.) GSH 1200 mg/kg/day (n = 24 and 14, respectively) for 7 days. In the G-100-day protocol, GSH-treated rats showed significantly lower renal G content (2.79 +/- 0.8 vs. 3.61 +/- 1.4 micrograms/mg prot) coupled with lower plasma urea (153 +/- 79 vs. 188 +/- 61 mg/dL) and creatinine levels (1.63 +/- 1 vs. 2.45 +/- 1 mg/dL). As to renal oxidant/antioxidant balance, local GSH was increased (0.32 +/- 0.01 vs. 0.19 +/- 0.01 microgram/mg prot) while lipid peroxidation, determined by production of thiobarbituric acid reactive substances (TBARS), was decreased (0.35 +/- 0.02 vs. 0.52 +/- 0.02 nmol/mg prot). In the G-150-mg protocol, GSH-treated rats showed no differences in renal gentamicin content or in blood urea and creatinine levels, in spite of a significantly lower renal TBARS production and a significantly ...Continue Reading

References

Jun 1, 1979·Analytical Biochemistry·H OhkawaK Yagi
Jan 1, 1979·Antimicrobial Agents and Chemotherapy·R BlochD R Maxwell
Oct 1, 1978·Toxicology and Applied Pharmacology·R J McMurtryJ R Mitchell
Apr 1, 1976·Proceedings of the Society for Experimental Biology and Medicine·W M BennettG A Porter
Jan 1, 1992·Renal Failure·S V Shah, P D Walker
Jan 1, 1992·Renal Failure·J M Weinberg
Oct 1, 1991·Kidney International·O F Dos SantosN Schor
Aug 1, 1991·Kidney International·S N HeymanF H Epstein
Feb 1, 1990·The Journal of Clinical Investigation·L J MandelW R Jacobs
Apr 1, 1989·Kidney International·W L GouveaC A Vaamonde
Feb 1, 1988·The Journal of Clinical Investigation·P D Walker, S V Shah
Aug 1, 1988·Kidney International·R G SchnellmannL J Mandel
Mar 1, 1985·Journal of Clinical Pharmacology·A Whelton
Feb 1, 1972·Clinica Chimica Acta; International Journal of Clinical Chemistry·J E PetesR Haschen
Jan 1, 1983·Annual Review of Biochemistry·A Meister, M E Anderson

❮ Previous
Next ❯

Citations

Mar 19, 1999·Hearing Research·S H Sha, J Schacht
Jan 23, 1999·Free Radical Biology & Medicine·S H Sha, J Schacht
Sep 11, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Yaremi QuirosFrancisco J López-Hernández

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.